Covid-19 vaccine: Serum Institute gets nod from DCGI to resume trials
After the adverse effect of Oxford's much-anticipated vaccine being developed with UK firm AstraZeneca, the clinical trials across the world ...
After the adverse effect of Oxford's much-anticipated vaccine being developed with UK firm AstraZeneca, the clinical trials across the world ...
The phase 2 human clinical trial of the Oxford Covid-19 vaccine candidate in the country by Pune-based Serum Institute of India (SII) is set to begin. ...